Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanercept.

Gyldenløve, M; Zachariae, C; Jensen, P; Griehsel, H; Ståhle, M; Skov, L

Gyldenløve, M; Zachariae, C; Jensen, P; Griehsel, H; Ståhle, M; Skov, L.

Afiliação

Gyldenløve M; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Zachariae C; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Jensen P; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Griehsel H; Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Ståhle M; Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Skov L; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

J Eur Acad Dermatol Venereol ; 31(12): e518-e519, 2017 Dec.

Article em En | MEDLINE | ID: mdl-28557009

Assuntos

Adalimumab/imunologia; Adalimumab/farmacologia; Anti-Inflamatórios/farmacologia; Anticorpos/sangue; Etanercepte/imunologia; Etanercepte/farmacologia; Psoríase/sangue; Adalimumab/uso terapêutico; Adolescente; Adulto; Idoso; Anti-Inflamatórios/imunologia; Anti-Inflamatórios/uso terapêutico; Etanercepte/uso terapêutico; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Psoríase/tratamento farmacológico; Resultado do Tratamento; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Adalimumab / Etanercepte / Anti-Inflamatórios / Anticorpos Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google